Thrombocytopenia 2 (THC2) is an inherited disorder caused by monoallelic single nucleotide substitutions in the 5′UTR of the ANKRD26 gene. Patients have thrombocytopenia and increased risk of myeloid malignancies, in particular, acute myeloid leukemia (AML). Given the association of variants in the ANKRD26 5′UTR with myeloid neoplasms, we investigated whether, and to what extent, mutations in this region contribute to apparently sporadic AML. To this end, we studied 250 consecutive, non-familial, adult AML patients and screened the first exon of ANKRD26 including the 5′UTR. We found variants in four patients. One patient had the c.-125T>G substitution in the 5′UTR, while three patients carried two different variants in the 5′ end of the ANKRD26 coding region (c.3G>A or c.105C>G). Review of medical history showed that the patient carrying the c.-125T>G was actually affected by typical but unrecognized THC2, highlighting that some apparently sporadic AML cases represent the evolution of a well-characterized familial predisposition disorder. As regards the c.3G>A and the c.105C>G, we found that both variants result in the synthesis of N-terminal truncated ANKRD26 isoforms, which are stable and functional in cells, in particular, have a strong ability to activate the MAPK/ERK signaling pathway. Moreover, investigation of one patient with the c.3G>A showed that mutation was associated with strong ANKRD26 overexpression in vivo, which is the proposed mechanism for predisposition to AML in THC2 patients. These data provide evidence that N-terminal ANKRD26 truncating mutations play a potential pathogenetic role in AML. Recognition of AML patients with germline ANKRD26 pathogenetic variants is mandatory for selection of donors for bone marrow transplantation.

Marconi, C., Canobbio, I., Bozzi, V., Pippucci, T., Simonetti, G., Melazzini, F., et al. (2017). 5′UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemia. JOURNAL OF HEMATOLOGY & ONCOLOGY, 10(1), 10-18 [10.1186/s13045-016-0382-y].

5′UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemia

MARCONI, CATERINA;Pippucci, Tommaso;SIMONETTI, GIORGIA;MARTINELLI, GIOVANNI;SERI, MARCO;
2017

Abstract

Thrombocytopenia 2 (THC2) is an inherited disorder caused by monoallelic single nucleotide substitutions in the 5′UTR of the ANKRD26 gene. Patients have thrombocytopenia and increased risk of myeloid malignancies, in particular, acute myeloid leukemia (AML). Given the association of variants in the ANKRD26 5′UTR with myeloid neoplasms, we investigated whether, and to what extent, mutations in this region contribute to apparently sporadic AML. To this end, we studied 250 consecutive, non-familial, adult AML patients and screened the first exon of ANKRD26 including the 5′UTR. We found variants in four patients. One patient had the c.-125T>G substitution in the 5′UTR, while three patients carried two different variants in the 5′ end of the ANKRD26 coding region (c.3G>A or c.105C>G). Review of medical history showed that the patient carrying the c.-125T>G was actually affected by typical but unrecognized THC2, highlighting that some apparently sporadic AML cases represent the evolution of a well-characterized familial predisposition disorder. As regards the c.3G>A and the c.105C>G, we found that both variants result in the synthesis of N-terminal truncated ANKRD26 isoforms, which are stable and functional in cells, in particular, have a strong ability to activate the MAPK/ERK signaling pathway. Moreover, investigation of one patient with the c.3G>A showed that mutation was associated with strong ANKRD26 overexpression in vivo, which is the proposed mechanism for predisposition to AML in THC2 patients. These data provide evidence that N-terminal ANKRD26 truncating mutations play a potential pathogenetic role in AML. Recognition of AML patients with germline ANKRD26 pathogenetic variants is mandatory for selection of donors for bone marrow transplantation.
2017
Marconi, C., Canobbio, I., Bozzi, V., Pippucci, T., Simonetti, G., Melazzini, F., et al. (2017). 5′UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemia. JOURNAL OF HEMATOLOGY & ONCOLOGY, 10(1), 10-18 [10.1186/s13045-016-0382-y].
Marconi, Caterina; Canobbio, Ilaria; Bozzi, Valeria; Pippucci, Tommaso; Simonetti, Giorgia; Melazzini, Federica; Angori, Silvia; Martinelli, Giovanni;...espandi
File in questo prodotto:
File Dimensione Formato  
document(2).pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 559.84 kB
Formato Adobe PDF
559.84 kB Adobe PDF Visualizza/Apri
13045_2016_382_MOESM1_ESM.docx

accesso aperto

Descrizione: Table S1.
Tipo: File Supplementare
Licenza: Licenza per Accesso Aperto. Creative Commons Universal – Donazione al Pubblico Dominio (CC0 1.0)
Dimensione 200.25 kB
Formato Microsoft Word XML
200.25 kB Microsoft Word XML Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/578853
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 32
social impact